FILTER
Refine your search with the following facets to narrow down your results.
- pharmacovigilance 8
- vaccines 8
- cancer 6
- myocardial infarction 6
- stroke 6
- gene therapies 5
- medicine 5
- rare diseases 5
- bacterial infections 4
- hypertension 4
- pancreatic cancer 4
- reductions 4
- Marketing Authorization Application 3
- amyotrophic lateral sclerosis 3
- antibiotics 3
- bone marrow 3
- breast cancer 3
- cardiovascular diseases 3
- diabetes 3
- dialysis 3
- diseases 3
- high blood pressure 3
- inflammation 3
- inhibitors 3
- melanoma 3
- milestone payments 3
- multiple sclerosis 3
- pain 3
- sepsis 3
- tumors 3
- Brexit 2
- Covid-19 2
- Duchenne muscular dystrophy 2
- Friedreich's ataxia 2
- Iceland 2
- Life Sciences 2
- Norway 2
- Spain 2
- T cells 2
- Translarna 2
- actinic keratosis 2
- angina 2
- antibodies 2
- avelumab 2
- biomarker 2
- blood cancer 2
- cell therapies 2
- chemotherapy 2
- cholesterol 2
- coronaviruses 2
- erythropoietic protoporphyria 2
- hepatitis C 2
- hereditary angioedema 2
- hydroxyethyl starch 2
- infections 2
- infectious diseases 2
- interferon 2
- liver 2
- lung diseases 2
- merkel cell carcinoma 2
- multiple myeloma 2
- non-Hodgkin lymphoma 2
- pandemic influenza 2
- plasticity 2
- pneumonia 2
- protease inhibitors 2
- regeneration 2
- solution 2
- spinal cord injuries 2
- vaccine development 2
- validation 2
- venous thromboembolism 2
- AA amyloidosis 1
- AIDS 1
- Alzheimer's disease 1
- China 1
- Cladribine 1
- Crohn's disease 1
- Cushing's disease 1
- Daklinza 1
- Ebola 1
- Expression 1
- Exviera 1
- Finland 1
- Formation 1
- Gaucher disease 1
- Germany 1
- Greece 1
- HIV 1
- Hodgkin lymphoma 1
- Holoclar 1
- Mycobacterium tuberculosis 1
- Parkinson's disease 1
- Plasmodium falciparum 1
- Pompe disease 1
- European Medicines Agency (EMA) 122
- Merck KGaA 7
- Novartis International AG 5
- Andrew Lloyd & Associates 3
- Biofrontera AG 3
- Citigate Dewe Rogerson 3
- EuropaBio 3
- Expedeon AG 3
- Genzyme Corporation 3
- GlaxoSmithKline plc (GSK) 3
- Janssen-Cilag N.V. 3
- Pfizer Inc. 3
- U. S. Food and Drug Administration (FDA) 3
- Amsterdam Molecular Therapeutics (AMT) B.V. 2
- Genmab A/S 2
- Kiadis Pharma BV 2
- Merck Serono International S.A. 2
- Oxurion nv 2
- Provepharm SAS 2
- Santhera Pharmaceuticals AG 2
- UCB S.A. 2
- sanofi-aventis Groupe 2
- Æterna Zentaris Inc. 2
- Actelion Pharmaceuticals Ltd 1
- Active Biotech AB 1
- AiCuris GmbH & Co. KG 1
- Ark Therapeutics Group plc 1
- Basilea Pharmaceutica AG 1
- BioMarin Pharmaceutical Inc. 1
- Biogen Inc. 1
- Bionovo, Inc. 1
- Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM) 1
- CV Therapeutics, Inc. (CVT) 1
- Clavis Pharma ASA 1
- Clinuvel Pharmaceuticals Limited 1
- CureVac AG 1
- Cyclacel Pharmaceuticals, Inc 1
- Eisai Co., Ltd 1
- Eisai Europe Ltd. 1
- F. Hoffmann-La Roche AG 1
- FORMAC Pharmaceuticals N.V. 1
- FlandersBio 1
- GPC Biotech AG 1
- GVK Biosciences Private Limited 1
- Gendux Molecular Limited 1
- Genentech, Inc. 1
- Genta Inc. 1
- Hybrigenics 1
- Intercell AG 1
- Invitrogen Corporation 1
- Jerini AG 1
- Johnson & Johnson 1
- Keryx Biopharmaceuticals, Inc. 1
- MediGene AG 1
- Merck Sharp & Dohme Limited 1
- Neurochem Inc. 1
- NicOx S.A. 1
- Packer Forbes 1
- Pharming Group N.V. 1
- Stage cell therapeutics GmbH 1
- Swedish Orphan Biovitrum 1
- Takeda Pharmaceutical Company Limited 1
- TiGenix NV 1
- Tibotec Pharmaceuticals Ltd. 1
- UCB Pharma S.A. 1
- b3c communications 1
- t2cure GmbH 1
122 Current news of European Medicines Agency
FILTERS
Refine your search with the following facets to narrow down your results.
- pharmacovigilance 8
- vaccines 8
- cancer 6
- myocardial infarction 6
- stroke 6
- gene therapies 5
- medicine 5
- rare diseases 5
- bacterial infections 4
- hypertension 4
- pancreatic cancer 4
- reductions 4
- Marketing Authorization Application 3
- amyotrophic lateral sclerosis 3
- antibiotics 3
- bone marrow 3
- breast cancer 3
- cardiovascular diseases 3
- diabetes 3
- dialysis 3
- diseases 3
- high blood pressure 3
- inflammation 3
- inhibitors 3
- melanoma 3
- milestone payments 3
- multiple sclerosis 3
- pain 3
- sepsis 3
- tumors 3
- Brexit 2
- Covid-19 2
- Duchenne muscular dystrophy 2
- Friedreich's ataxia 2
- Iceland 2
- Life Sciences 2
- Norway 2
- Spain 2
- T cells 2
- Translarna 2
- actinic keratosis 2
- angina 2
- antibodies 2
- avelumab 2
- biomarker 2
- blood cancer 2
- cell therapies 2
- chemotherapy 2
- cholesterol 2
- coronaviruses 2
- erythropoietic protoporphyria 2
- hepatitis C 2
- hereditary angioedema 2
- hydroxyethyl starch 2
- infections 2
- infectious diseases 2
- interferon 2
- liver 2
- lung diseases 2
- merkel cell carcinoma 2
- multiple myeloma 2
- non-Hodgkin lymphoma 2
- pandemic influenza 2
- plasticity 2
- pneumonia 2
- protease inhibitors 2
- regeneration 2
- solution 2
- spinal cord injuries 2
- vaccine development 2
- validation 2
- venous thromboembolism 2
- AA amyloidosis 1
- AIDS 1
- Alzheimer's disease 1
- China 1
- Cladribine 1
- Crohn's disease 1
- Cushing's disease 1
- Daklinza 1
- Ebola 1
- Expression 1
- Exviera 1
- Finland 1
- Formation 1
- Gaucher disease 1
- Germany 1
- Greece 1
- HIV 1
- Hodgkin lymphoma 1
- Holoclar 1
- Mycobacterium tuberculosis 1
- Parkinson's disease 1
- Plasmodium falciparum 1
- Pompe disease 1
- European Medicines Agency (EMA) 122
- Merck KGaA 7
- Novartis International AG 5
- Andrew Lloyd & Associates 3
- Biofrontera AG 3
- Citigate Dewe Rogerson 3
- EuropaBio 3
- Expedeon AG 3
- Genzyme Corporation 3
- GlaxoSmithKline plc (GSK) 3
- Janssen-Cilag N.V. 3
- Pfizer Inc. 3
- U. S. Food and Drug Administration (FDA) 3
- Amsterdam Molecular Therapeutics (AMT) B.V. 2
- Genmab A/S 2
- Kiadis Pharma BV 2
- Merck Serono International S.A. 2
- Oxurion nv 2
- Provepharm SAS 2
- Santhera Pharmaceuticals AG 2
- UCB S.A. 2
- sanofi-aventis Groupe 2
- Æterna Zentaris Inc. 2
- Actelion Pharmaceuticals Ltd 1
- Active Biotech AB 1
- AiCuris GmbH & Co. KG 1
- Ark Therapeutics Group plc 1
- Basilea Pharmaceutica AG 1
- BioMarin Pharmaceutical Inc. 1
- Biogen Inc. 1
- Bionovo, Inc. 1
- Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM) 1
- CV Therapeutics, Inc. (CVT) 1
- Clavis Pharma ASA 1
- Clinuvel Pharmaceuticals Limited 1
- CureVac AG 1
- Cyclacel Pharmaceuticals, Inc 1
- Eisai Co., Ltd 1
- Eisai Europe Ltd. 1
- F. Hoffmann-La Roche AG 1
- FORMAC Pharmaceuticals N.V. 1
- FlandersBio 1
- GPC Biotech AG 1
- GVK Biosciences Private Limited 1
- Gendux Molecular Limited 1
- Genentech, Inc. 1
- Genta Inc. 1
- Hybrigenics 1
- Intercell AG 1
- Invitrogen Corporation 1
- Jerini AG 1
- Johnson & Johnson 1
- Keryx Biopharmaceuticals, Inc. 1
- MediGene AG 1
- Merck Sharp & Dohme Limited 1
- Neurochem Inc. 1
- NicOx S.A. 1
- Packer Forbes 1
- Pharming Group N.V. 1
- Stage cell therapeutics GmbH 1
- Swedish Orphan Biovitrum 1
- Takeda Pharmaceutical Company Limited 1
- TiGenix NV 1
- Tibotec Pharmaceuticals Ltd. 1
- UCB Pharma S.A. 1
- b3c communications 1
- t2cure GmbH 1